Macular Degeneration Information
Eylea Approved for Macular Degeneration Treatment
The FDA has granted approval to the age-related macular degeneration treatment Eylea, clearing the way to provide another form of treatment for the leading eye disease causing blindness in the elderly. Similar to other macular degeneration drugs, Eylea inhibits the growth of abnormal blood vessels in the retina. These abnormal blood vessels are charactestic for the most severe and fastest … [Read More...]
Genetic Mutation Identifies High Risk of Macular Degeneration
A rare genetic mutation has been identified that predicts a high risk of macular degeneration. Macular degeneration is seen as the leading cause of blindness in the elderly. Having a genetic mutation discovered that may predict the risk of the eye disease will provide insight into developing new treatments and in prevention. Previous research had identified genetic variants that predict … [Read More...]
Possible Lucentis Side-Effects Discovered
Researchers may have uncovered a side-effect in the macular degeneration treatment Lucentis. Lucentis is the leading treatment for wet macular degeneration. However, researchers at the Mayo Clinic have discovered this drug may cause increased pressure inside the eyes of some patients who have received the drug to treat their eye disease. Dr. Sophie Bakri began noticing patients in her … [Read More...]
Macular Degeneration Drugs
With age-related macular degeneration recognized as the leading cause of blindness in the aging population, developing drugs to combat the eye disease has become a priority for many pharmaceutical companies. While there is no cure for macular degeneration, there are several drugs on the market used to treat the most severe form of the eye disease, wet macular degeneration. There is no drug to … [Read More...]
Daily Aspirin Increases Risk of Macular Degeneration
New research has shown seniors taking a daily dose of aspirin are twice as likely to develop late stage macular degeneration than people who don't take the drug. While aspirin does not directly cause macular degeneration, researchers are concerned that aspirin may increase the severity of the eye disease. When you consider the number of seniors who take a daily dose of aspirin to lower their … [Read More...]
Gene Therapy and Stem Cell Therapy for Macular Degeneration
Macular Degeneration has been identified as a leading cause of blindness and vision loss among older people. Because of better diagnostic techniques in recent years, more and more people are being diagnosed with this eye disease. Research has turned to both gene therapy and stem cell therapy as potential treatments for macular degeneration. It has shown promise in several recent clinical … [Read More...]
Avastin Injections Reported to Cause Blindness
Health authorities in Florida and Tennessee have indicated several people suffering from wet macular degeneration recently treated with the Avastin have been blinded. Approved initially as a cancer drug, Avastin has been used to treat macular degeneration as an off-label treatment because it costs approximately $50 per treatment compared to $2,000 for Lucentis. Macular degeneration is the … [Read More...]
Eylea Treatment for Macular Degeneration
A new drug has been developed as a treatment for macular degeneration. The drug named Eylea will compete directly with Lucentis, the current leading treatment for the eye disease. It is expected Eylea will be injected every eight weeks into the eyes of those patients suffering from wet macular degeneration, a degenerative eye disease characterised by the formation of abnormal blood vessels … [Read More...]
iVeena Implants May Assist Macular Degeneration Patients
Patients suffering from wet macular degeneration are usually treated with injections of Lucentis or Avastin. These intravitreal injections are described as painful and stressful. Fortunately researchers have developed iVenna implants that may spare macular degeneration patients the pain and stress of having eye injections. Macular degeneration is the leading cause of blindness that … [Read More...]
Macular Degeneration Risk Model Predicts Risk
Researchers have developed risk assessment model to help predict the development of age-related macular degeneration. In a report published in the Archives of Ophthalmology researchers have indicated should be able to identify people with early forms of macular degeneration who are at the greatest risk of having the eye disease progress to the advanced form. Macular degeneration is the … [Read More...]
Recent Comments